Применение метабиотиков в клинической гериатрической практике (Методические рекомендации Российской ассоциации геронтологов и гериатров)
https://doi.org/10.37586/2686-8636-2-2026-164-174
Аннотация
В методических рекомендациях рассматриваются сложные взаимоотношения между кишечной микробиотой и процессами старения, анализируется потенциал терапевтических подходов, направленных на коррекцию микробиома с применением метабиотиков, как перспективного подхода для увеличения продолжительности и качества жизни у лиц гериатрического профиля, представлены преимущества применения метабиотиков в комплексной терапии некоторых заболеваний у лиц пожилого и старческого возраста.
Об авторах
А. А. Машарова
ФГАОУ ВО РНИМУ им. Н. И. Пирогова Минздрава России (Пироговский Университет), ОСП «Российский геронтологический научно-клинический центр»
Россия
Россия
д.м.н., профессор, врач-гастроэнтеролог, старший научный сотрудник лаборатории общей гериатрии
Москва
М. С. Арефьева
ФГАОУ ВО РНИМУ им. Н. И. Пирогова Минздрава России (Пироговский Университет), ОСП «Российский геронтологический научно-клинический центр»
Россия
Россия
Арефьева Мария Сергеевна, м.н.с. лаборатории общей гериатрии, гериатр, врач функциональной диагностики
Москва
О. Н. Ткачева
ФГАОУ ВО РНИМУ им. Н. И. Пирогова Минздрава России (Пироговский Университет), ОСП «Российский геронтологический научно-клинический центр»
Россия
Россия
д.м.н., профессор, директор
Москва
Список литературы
1. Hou Y., Dan X., Babbar M., et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019 ; 15 (10) : 565–581. DOI: 10.1038/s41582-019-0244-7.
2. Gyriki D., Nikolaidis C., Stavropoulou E., et al. Exploring the gut microbiome’s role in inflammatory bowel disease: insights and interventions. J. Pers. Med. 2024 ; 14 (5) : 507. DOI: 10.3390/jpm14050507.
3. Jandhyala S. M., Talukdar R., Subramanyam C., et al. Role of the normal gut microbiota. World J. Gastroenterol. 2015 ; 21 (29) : 8787–8803. DOI: 10.3748/wjg.v21.i29.8787.
4. Prosty C., Katergi K., Papenburg J., et al. Causal role of the gut microbiome in certain human diseases: a narrative review. eGastroenterology. 2024 ; 2 (3) : e100086. DOI: 10.1136/egastro-2024-100086.
5. Haran J. P., McCormick B. A. Aging, frailty, and the microbiome-how dysbiosis influences human aging and disease. Gastroenterology. 2021 ; 160 (2) : 507–523. DOI: 10.1053/j.gastro.2020.09.060.
6. Ардатская М. Д., Бельмер С. В., Добрица В. П. и др. Дисбиоз (дисбактериоз) кишечника: современное состояние проблемы, комплексная диагностика и лечебная коррекция // Экспериментальная и клиническая гастроэнтерология. — 2015. — Т. 5, № 117. — С. 13–50.
7. Gyriki D., Nikolaidis C. G., Bezirtzoglou E., et al. The gut microbiota and aging: interactions, implications, and interventions. Front Aging. 2025 ; 6 : 1452917. DOI: 10.3389/fragi.2025.1452917.
8. Shenderov B. A., Sinitsa A. V., Zakharchenko M. M., Lang C. Metabiotics: Present State, Challenges and Perspectives. Cham: Springer Nature Switzerland AG; 2020. 122 p. DOI: 10.1007/978-3-030-34167-1.
9. Ивашкин В. Т., Горелов А. В., Абдулганиева Д. И. и др. Методические рекомендации Научного сообщества по содействию клиническому изучению микробиома человека (НСОИМ) и Российской гастроэнтерологической ассоциации (РГА) по применению пробиотиков, пребиотиков, синбиотиков, метабиотиков и обогащенных ими функциональных пищевых продуктов для лечения и профилактики заболеваний гастроэнтерологического профиля у взрослых и детей // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. — 2024. — Т. 34, № 4. — С. 113–136.
10. Claesson M. J., Cusack S., O’Sullivan O., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 2011 ; 108 (Suppl 1) : 4586–4591. DOI: 10.1073/pnas.1000097107.
11. Rinninella E., Raoul P., Cintoni M., et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019 ; 7 (1) : 14. DOI: 10.3390/microorganisms7010014.
12. Mariat D., Firmesse O., Levenez F., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009 ; 9: 123. DOI: 10.1186/1471-2180-9-123.
13. Biagi E., Nylund L., Candela M., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010 ; 5 (6) : e10667. DOI: 10.1371/journal.pone.0010667.
14. Odamaki T., Kato K., Sugahara H., et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016 ; 16 (1) : 90. DOI: 10.1186/s12866-016-0708-5.
15. Vaiserman A., Romanenko M., Piven L., et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 2020 ; 20 (1) : 221. DOI: 10.1186/s12866-020-01903-7.
16. Biagi E., Nylund L., Candela M., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010 ; 5 (6) : e10667. DOI: 10.1371/journal.pone.0010667.
17. López-Otín C., Blasco M. A., Partridge L., Serrano M., Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023 ; 186 (2) : 243–278. DOI: 10.1016/j.cell.2022.11.001.
18. Park S.-H., Kim K.-A., Ahn Y.-T., et al. Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages. BMC Microbiol. 2015 ; 15 : 49. DOI: 10.1186/s12866-015-0386-8.
19. Yu X., Wu X., Qiu L., et al. Analysis of the intestinal microbial community structure of healthy and long-living elderly residents in Gaotian Village of Liuyang City. Appl Microbiol Biotechnol. 2015 ; 99 (21) : 9085–9095. DOI: 10.1007/s00253-015-6888-3.
20. Wu L., Zeng T., Zinellu A., Rubino S., Kelvin D. J., Carru C. A cross-sectional study of compositional and functional profiles of gut microbiota in Sardinian centenarians. mSystems. 2019 ; 4 (4) : e00325-19. DOI: 10.1128/mSystems.00325-19.
21. Liu P., Wang Y., Yang G., et al. The role of shortchain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis. Pharmacol Res. 2021 ; 165 : 105420. DOI: 10.1016/j.phrs.2021.105420.
22. Sato Y., Atarashi K., Plichta D. R., et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature. 2021 ; 599 (7885) : 458–464. DOI: 10.1038/s41586-021-03832-5.
23. Salazar J., Durán P., Díaz M. P., et al. Exploring the relationship between the gut microbiota and ageing: a possible age modulator. Int J Environ Res Public Health. 2023 ; 20 (10) : 5845. DOI: 10.3390/ijerph20105845.
24. Brüssow H. Problems with the concept of gut microbiota dysbiosis. Microb Biotechnol. 2020 ; 13 (2) : 423–434. DOI: 10.1111/1751-7915.13479.
25. Dogra S. K., Doré J., Damak S. Gut microbiota resilience: definition, link to health and strategies for intervention. Front Microbiol. 2020 ; 11 : 572921. DOI: 10.3389/fmicb.2020.572921.
26. Liu F., Yin J., Wang J., Xu X. Food for the elderly based on sensory perception: A review. Curr Res Food Sci. 2022 ; 5 : 1550–1558. DOI: 10.1016/j.crfs.2022.09.014.
27. Woodmansey E. J., McMurdo M. E. T., Macfarlane G. T., Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotictreated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol. 2004 ; 70 (10) : 6113–6122. DOI: 10.1128/AEM.70.10.6113-6122.2004.
28. Koliada A., Syzenko G., Moseiko V., et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017 ; 17 (1) : 120. DOI: 10.1186/s12866-017-1027-1.
29. Wegierska A. E., Charitos I. A., Topi S., et al. The Connection Between Physical Exercise and Gut Microbiota: Implications for Competitive Sports Athletes. Sports Med. 2022 ; 52 (10) : 2355–2369. DOI: 10.1007/s40279-022-01696-x.
30. Yu L., Bi M., Xie L. Correlation Between Polypharmacy and Gut Microbiota Compositional Changes in Older People Who Were Treated with Multidrug Therapy. Rejuvenation Res. 2025 ; 28 (6) : 291–299. DOI: 10.1177/15491684251365971.
31. Jeffery I. B., Lynch D. B., O’Toole P. W. Composition and temporal stability of the gut microbiota in older persons. ISME J. 2016 ; 10 (1) : 170–182. DOI: 10.1038/ismej.2015.88.
32. Kim B.-S., Choi C. W., Shin H., et al. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups. J Microbiol Biotechnol. 2019 ; 29 (3) : 429–440. DOI: 10.4014/jmb.1811.11023.
33. Zhu Q., Jiang S., Du G. Effects of exercise frequency on the gut microbiota in elderly individuals. Microbiologyopen. 2020 ; 9 (8) : e1053. DOI: 10.1002/mbo3.1053.
34. Conlon M. A., Bird A. R. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014 ; 7 (1) : 17–44. DOI: 10.3390/nu7010017.
35. Lutgendorff F., Akkermans L. M. A., Söderholm J. D. The role of microbiota and probiotics in stress-induced gastrointestinal damage. Curr Mol Med. 2008 ; 8 (4) : 282–298. DOI: 10.2174/156652408784533779.
36. Coman V., Vodnar D. C. Gut microbiota and old age: modulating factors and interventions for healthy longevity. Exp Gerontol. 2020 ; 141 : 111095. DOI: 10.1016/j.exger.2020.111095.
37. Ramirez J., Guarner F., Bustos Fernandez L., et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020 ; 10 : 572912. DOI: 10.3389/fcimb.2020.572912.
38. Falony G., Joossens M., Vieira-Silva S., et al. Populationlevel analysis of gut microbiome variation. Science. 2016 ; 352 (6285) : 560–564. DOI: 10.1126/science.aad3503.
39. Hou K., Wu Z.-X., Chen X.-Y., et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022 ; 7 (1) : 135–228. DOI: 10.1038/s41392-022-00974-4.
40. Imhann F., Vich Vila A., Bonder M. J., et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017 ; 8 (4) : 351–358. DOI: 10.1080/19490976.2017.1284732.
41. Tian L., Huang C., Fu W., et al. Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota. Front Pharmacol. 2023 ; 14 : 1217306. DOI: 10.3389/fphar.2023.1217306.
42. World Gastroenterology Organisation. Probiotics and prebiotics. 2023. https://www.worldgastroenterology.org/guidelines/probiotics-and-prebiotics. Accessed March 15, 2026.
43. Davani-Davari D., Negahdaripour M., Karimzadeh M., et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019 ; 8 (3) : 92. DOI: 10.3390/foods8030092.
44. Swanson K. S., Gibson G. R., Hutkins R., et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020 ; 17 (11) : 687–701. DOI: 10.1038/s41575-020-0344-2.
45. Ma L., Tu H., Chen T. Postbiotics in human health: a narrative review. Nutrients. 2023 ; 15 (2) : 291. DOI: 10.3390/nu15020291.
46. Salminen S., Collado M. C., Endo A., et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021 ; 18 (9) : 649–667. DOI: 10.1038/s41575-021-00440-6.
47. Cicero A. F. G., Fogacci F., Bove M., et al. Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. Eur J Nutr. 2021 ; 60 (2) : 655–663. DOI: 10.1007/s00394-020-02271-8.
48. Yang D., Ren D., Zhang Y., et al. The gut microbiota dysbiosis in geriatric multimorbidity: pharmacotherapeutic implications, pathophysiological mechanisms, and precision modulation strategies. Ageing Res Rev. 2026 ; 115 : 103023. DOI: 10.1016/j.arr.2026.103023.
49. Biswas I., Das Mohapatra P. K. Recent advancement in metabiotics: a consortium with bioactive molecules after fermentation by probiotic bacteria with multidisciplinary application potential and future solution in health sector. Bioresour Technol Rep. 2023 ; 23 (9): 101583. DOI: 10.1016/j.biteb.2023.101583
50. Jang H. J., Lee N. K., Paik H. D. A narrative review on the advance of probiotics to metabiotics. J Microbiol Biotechnol. 2024 ; 34 (3) : 487–494. DOI: 10.4014/jmb.2311.11023.
51. Nataraj B. H., Shivanna S. K., Rao P., Nagpal R., Behare P. V. Evolutionary concepts in the functional biotics arena: a minireview. Food Sci Biotechnol. 2021 ; 30 (4) : 487–496. DOI: 10.1007/s10068-020-00818-3.
52. Shenderov B. A. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis. 2012 ; 23 : 17195. DOI: 10.3402/mehd.v23i0.17195.
53. Sheflin A. M., Whitney A. K., Weir T. L. Cancer-promoting effects of microbial dysbiosis. Curr Oncol Rep. 2014 ; 16 (10) : 406. DOI: 10.1007/s11912-014-0406-0.
54. Caselli M., Vaira G., Calo G., et al. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr. 2011 ; 2 (5) : 372–376. DOI: 10.3945/an.111.000604.
55. Shenderov B. A. Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis. 2013 ; 24. DOI: 10.3402/mehd.v24i0.20399.
56. Shaikh A. M., Sreeja V. Metabiotics and their health benefits. Int J Food Ferment Technol. 2017 ; 6 (1) : 11–23. DOI: 10.5958/2321-712X.2017.00002.3.
57. Tsai Y. C., Cheng L. H., Liu Y. W., et al. Gerobiotics: probiotics targeting fundamental aging processes. Biosci Microbiota Food Health. 2021 ; 40 (1) : 1–11. DOI: 10.12938/bmfh.2020-026.
58. Chen L. H., Huang S. Y., Huang K. C., et al. Lactobacillus paracasei PS23 decelerated age-related muscle loss by ensuring mitochondrial function in SAMP8 mice. Aging (Albany NY). 2019 ; 11 (2) : 756–770. DOI: 10.18632/aging.101782.
59. Серкова М. Ю., Бакулин И. Г., Авалуева Е. Б., и др. Антибиотик-ассоциированная диарея. Практические вопросы диагностики и лечения у пациентов пожилого и старческого возраста // Первичная медико-санитарная помощь. — 2025. — Т. 2, № 2. — С. 64–72.
60. Dukowicz A. C., Lacy B. E., Levine G. M. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 ; 3 (2 ): 112–122.
61. Martyniak A., Wójcicka M., Rogatko I., et al. A comprehensive review of the usefulness of prebiotics, probiotics, and postbiotics in the diagnosis and treatment of small intestine bacterial overgrowth. Microorganisms. 2025 ; 13 (1) : 57. DOI: 10.3390/microorganisms13010057
62. Yoo J. Y., Kim S. S. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. 2016 ; 8 (3) : 173. DOI: 10.3390/nu8030173.
63. Musso G., Gambino R., Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010 ; 33 (10) : 2277–2284. DOI: 10.2337/dc10-0556.
64. Bauer K. C., Rees T., Finlay B. B. The gut microbiota-brain axis expands neurologic function: a nervous rapport. Bioessays. 2019 ; 41 (10) : 1800268. DOI: 10.1002/bies.201800268.
65. Cheng L. H., Liu Y. W., Wu C. C., et al. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. J Food Drug Anal. 2019 ; 27 (3) : 632–648. DOI: 10.1016/j.jfda.2019.01.002.
66. Takahashi S., Kawamura T., Kanda Y., et al. Activation of CD1d-independent NK1.1+ T cells in the large intestine by lactobacilli. Immunol Lett. 2006 ; 102 (1) : 74–78. DOI: 10.1016/j.imlet.2005.07.003.
67. Fukui M., Fujino T., Tsutsui K., et al. The tumorpreventing effect of a mixture of several lactic acid bacteria on 1,2-dimethylhydrazine-induced colon carcinogenesis in mice. Oncol Rep. 2001 ; 8 (5) : 1073–1078. DOI: 10.3892/or.8.5.1073.
68. Попова Т. С., Тропская Н. С., Черненькая Т. В. и др. Влияние экстракта брожения кисломолочных бактерий Дайго на состав микрофлоры и моторную функцию кишечника при экспериментальном дисбиозе // Трансплантология. — 2016. — № 4. — С. 39–47.
69. Odashiro K., Fukata M., Saito K., et al. The effects of lactic acid bacteria-fermented soymilk extract on patients with colonic polyps: a randomized, double-blind, placebocontrolled pilot trial. J Integr Stud Diet Habits. 2014 ; 25 (1) :20–25. DOI: 10.2740/jisdh.25.20.
70. Fukuchi M., Sugita M., Banjo M., et al. The impact of a competitive event and the efficacy of a lactic acid bacteriafermented soymilk extract on the gut microbiota and urinary metabolites of endurance athletes: an open-label pilot study. PLoS One. 2022 ; 17 (1) : e0262906. DOI: 10.1371/journal.pone.0262906.
Рецензия
Для цитирования:
Машарова А.А., Арефьева М.С., Ткачева О.Н. Применение метабиотиков в клинической гериатрической практике (Методические рекомендации Российской ассоциации геронтологов и гериатров). Российский журнал гериатрической медицины. 2026;(2):164-174. https://doi.org/10.37586/2686-8636-2-2026-164-174
For citation:
Masharova A.A., Arefeva M.S., Tkacheva O.N. The use of metabiotics in clinical geriatric practice (Guidelines of the Russian Association of Gerontologists and Geriatricians). Russian Journal of Geriatric Medicine. 2026;(2):164-174. (In Russ.) https://doi.org/10.37586/2686-8636-2-2026-164-174
Просмотров:
479
JATS XML
Послать статью по эл. почте 